The anxiolytic effect of chronic inositol depends on the baseline level of anxiety

Journal of Neural Transmission

Volumn 107, Issue 2, 2000, Pages 241-253

  Kofman, O ^a   Einat, H ^a   Cohen, H ^a   Tenne, H ^a   Shoshana, C ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Anxiety; Elevated plus maze; Inositol; Stress

Indexed keywords

ANXIOLYTIC AGENT; INOSITOL; LITHIUM; PHOSPHATIDYLINOSITIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR; CAT; CONTROLLED STUDY; DIETARY INTAKE; MALE; MAZE TEST; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STRESS; TRANQUILIZING ACTIVITY;

EID: 0033962712     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050020     Document Type: Article

References (47)

1. Adamec RE, Shallow T (1993) Lasting effects on rodent anxiety of a single exposure to a cat. Physiol Behav 54: 101-109
2. Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH (1995) Inositol treatment for panic disorder: a double-blind placebo-controlled crossover trial. Am J Psychiatry 152: 1084-1086
3. 1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol Biochem Behav 58: 593-603
4. Cohen H, Friedberg S, Matar M, Kotler M, Kaplan Z (1997a) Interaction of CCK-4 induced anxiety and post-cat exposure anxiety in rats. Depression and Anxiety 4: 144-145
5. Cohen H, Kotler M, Kaplan Z, Matar M, Kofman O, Belmaker RH (1997b) Inositol has behavioral effects with adaptation after chronic administration. J Neural Transm 104: 299-305
6. Cratty MS, Ward HE, Johnson EA, Azzaro AJ, Birkle DL (1995) Prenatal stress increases corticotropin-releasing factor (CRF) content and release in amygdala minces. Brain Res 675: 297-302
7. 2 adrenoreceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice. Psychopharmacol 98: 189-193
8. Einat H, Elkabaz-Shwortz Z, Cohen H, Kofman O, Belmaker RH (1998) Chronic epi-inositol has an anxiolytic-like effect in the plus-maze model in rats. Int J Neuropsychopharmacol 1: 31-34
9. Einat H, Karbovski H, Koik J, Tsalah D, Belmaker RH (1999) Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacol 144: 158-162
10. Falter U, Gower AJ, Gobert J (1992) Resistance of baseline activity in the elevated plus-maze to exogenous influences. Behav Pharmacol 3: 123-128
11. Fux M, Levine J, Aviv A, Belmaker RH (1996) Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry 153: 1219-1221
12. 2A receptor-mediated inositol phosphate production in the spontaneously hypertensive rat and Lewis rat strains. Neurosci Lett 236: 112-116
13. Guilé J-M (1996) Sertraline-induced behavioral activation during the treatment of an adolescent with major depression. J Child Adolesc Psychopharmacol 6: 281-285
14. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M (1992) Inositol supplementation in premature infants with respiratory distress syndrome. NEJM 326: 1233-1239
15. Holub BJ (1984) Nutritional, biochemical and clinical aspects of inositol and phosphatidylinositol metabolism. Can J Physiol Pharmacol 62: 1-8
16. +-ATPase activity in isolated membrane fraction from sciatic nerves of stereptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes 40: 558-567
17. Kofman O, Belmaker RH (1993) Biochemical, behavioral and clinical studies of the role of inositol in lithium treatment and depression. Biol Psychiatry 34: 839-852
18. Kofman O, Bersudsky Y, Vinnitsky I, Alpert C, Belmaker RH (1993) The effect of peripheral inositol injection on rat motor activity models of depression. Isr J Med Sci 29: 580-586
19. Kofman O, Levin U, Alpert C (1995) Lithium attenuates hypokinesia induced by immobilization stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 19: 1081-1091
20. Kofman O, Agam G, Shapiro J, Spencer A (1998) Chronic dietary inositol enhances locomotor activity and brain inositol levels in rats. Psychopharmacol 139: 239-242
21. Levine J (1997) Controlled trials of inositol in psychiatry. Eur Neuropsychopharmacol 7: 147-155
22. Levine J, Chengappa KRN, Reddy R (1999) Acute myo-inositol enhances swimming activity in goldfish. J Neural Transm 106: 433-441
23. Manji HK, Bersudsky Y, Chen G, Belmaker RH, Potter WZ (1996) Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol. Neuropsychopharmacol 15: 370-381
24. Manji H, Bebchuk JM, Arfken CL, Strahl-Bevacqua J, Moore GJ (1998) Modulation of brain phosphoinositide signaling by lithium: relationship to therapeutic response in manic-depressive illness. Int J Neuropsychopharmacol 1 [Suppl 1]: S90
25. Martijena ID, Calvo N, Volosin M, Molina VA (1997) Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Res 752: 136-142
26. Michell RH (1997) The multiplying roles of inositol lipids and phosphates in cell control processes. Essays Biochem 32: 31-47
27. Patishi Y, Belmaker RH, Bersudsky Y, Kofman O (1996) A comparison of the ability of myo-inositol and epi-inositol to attenuate lithium-pilocarpine seizures in rats. Biol Psychiatry 39: 829-832
28. Patishi Y, Lubrich B, Berger M, van Calker D, Kofman O, Belmaker RH (1996) Differential uptake of myo-inositol in vivo into rat brain areas. Eur Neuropsychopharmacol 6: 73-76
29. Peters DAV (1982) Prenatal stress: effects on brain bogenic amine and plasma corticosterone levels. Pharmacol Biochem Behav 17: 721-725
30. Pontzer NJ, Madamba S, Siggins GR, Crews FT (1992) Concentrations of carbachol stimulating phosphoinositide hydrolysis cause a sustained decrease in membrane potential and firing rate: role of inositol and inositol polyphosphate second messengers. Brain Res 597: 189-199
31. 2) receptor induced homologous and hetrologous desensitization. Brain Res 631: 349-351
32. Richards MH, Belmaker RH (1996) Epi-inositol is biochemically active in reversing lithium effects on cytidine monophosphorylphosphatidate (CMP-PA). J Neural Transm 103: 1281-1285
33. Rodgers RJ, Dalvi A (1997) Anxiety, defence and the elevated plus maze. Neurosci Biobehav Rev 21: 801-810
34. Rodgers RJ, Johnson NJT (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52: 297-303
35. Rodríguez Echandía EL, Broitman ST, Fóscolo MR (1987) Effect of the chronic ingestion of chlorimipramine and desimpramine on the hole board response to acute stresses in male rats. Pharmacol Biochem Behav 26: 207-210
36. Sanchez C (1997) Acute stress enhances anxiolytic-like drug responses of mice tested in a black and white test box. Eur Neuropsychopharmacol 7: 283-288
37. Shimon H, Agam G, Belmaker RH, Hyde T, Kleinman JE (1997) Reduced inositol levels in frontal cortex of post-mortem brain from bipolar patients and suicides. Am J Psychiatry 154: 1148-1150
38. Shimon H, Sobolev Y, Davidson M, Haroutunian V, Belmaker RH, Agam G (1998) Inositol levels are decreased in postmortem brain of schizophrenic patients. Biol Psychiat 44: 428-432
39. Smith AJ, Freedman SB (1996) CCK-B receptor-mediated stimulation of polyphosphoinositide turnover in GH3 pituitary cells in response to cholecystokinin and pentagastrin. Life Sci 58: 883-895
40. Spector R (1988) Myo-inositol transport through the blood-brain barrier. Neurochem Res 137: 785-787
41. Thorré K, Chaouloff F, Sarre S, Meeusen R, Ebinger G, Michotte Y (1997) Differential effects of restraint stress on hippocampal 5-HT metabolism and extacellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res 772: 209-216
42. Wells WW (1989) Inositol deficiency states as a guide to inositol function. In: Michell RH, Drummond AH, Downes CP (eds) Inositol lipids in cell signalling. Academic Press, New York, pp 207-235
43. Williams MB, Jope RS (1995) Modulation by inositol of cholinergic-and serotonergic-induced seizures in lithium-treated rats. Brain Res 685: 169-178
44. Willner P (1991) Animal models as simulations of depression. Trends Pharmacol Sci 121: 131-136
45. Wright IK, Heaton M, Upton N, Marsden CD (1992) Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacol 107: 405-414
46. Yorek MA, Wiese TJ, Davidson EP, Dunlap JA, Stefani MR, Conner CE, Lattimer SA, Kamijo M, Greene DA (1993) Reduced motor nerve conduction velocity and Na+-K+-ATPase activity in rats maintained on L-fucose diet. Diabetes 42: 1401-1406
47. Zhang LJ, Lu XY, Han JS (1992) Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells. Biochem J 285: 847-850